Medical Devices & Consumables

Global ALK Positive Lung Cancer Treatment Market Insights, Forecast to 2030

ALK positive lung cancer treatment treats people get lung cancer with Anaplastic Lymphoma Kinase (ALK) mutation (the EML4-ALK fusion gene).
Market Analysis and Insights: Global ALK Positive Lung Cancer Treatment Market
The global ALK Positive Lung Cancer Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for ALK Positive Lung Cancer Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of ALK Positive Lung Cancer Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for ALK Positive Lung Cancer Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the ALK Positive Lung Cancer Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global ALK Positive Lung Cancer Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for ALK Positive Lung Cancer Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
F. Hoffmann-La Roche
Pfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
Segment by Type
Crizotinib
Alectinib
Ceritinib
Brigatinib
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of ALK Positive Lung Cancer Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ALK Positive Lung Cancer Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ALK Positive Lung Cancer Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Crizotinib
1.2.3 Alectinib
1.2.4 Ceritinib
1.2.5 Brigatinib
1.2.6 Other
1.3 Market by Application
1.3.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2019-2030)
2.2 Global ALK Positive Lung Cancer Treatment Growth Trends by Region
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ALK Positive Lung Cancer Treatment Historic Market Size by Region (2019-2024)
2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2025-2030)
2.3 ALK Positive Lung Cancer Treatment Market Dynamics
2.3.1 ALK Positive Lung Cancer Treatment Industry Trends
2.3.2 ALK Positive Lung Cancer Treatment Market Drivers
2.3.3 ALK Positive Lung Cancer Treatment Market Challenges
2.3.4 ALK Positive Lung Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue ALK Positive Lung Cancer Treatment by Players
3.1.1 Global ALK Positive Lung Cancer Treatment Revenue by Players (2019-2024)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2019-2024)
3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of ALK Positive Lung Cancer Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2023
3.5 Global Key Players of ALK Positive Lung Cancer Treatment Head office and Area Served
3.6 Global Key Players of ALK Positive Lung Cancer Treatment, Product and Application
3.7 Global Key Players of ALK Positive Lung Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ALK Positive Lung Cancer Treatment Breakdown Data by Type
4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2019-2024)
4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2025-2030)
5 ALK Positive Lung Cancer Treatment Breakdown Data by Application
5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2019-2024)
5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ALK Positive Lung Cancer Treatment Market Size (2019-2030)
6.2 North America ALK Positive Lung Cancer Treatment Market Size by Type
6.2.1 North America ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024)
6.2.2 North America ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030)
6.2.3 North America ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
6.3 North America ALK Positive Lung Cancer Treatment Market Size by Application
6.3.1 North America ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024)
6.3.2 North America ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030)
6.3.3 North America ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
6.4 North America ALK Positive Lung Cancer Treatment Market Size by Country
6.4.1 North America ALK Positive Lung Cancer Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)
6.4.3 North America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2019-2030)
7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type
7.2.1 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024)
7.2.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030)
7.2.3 Europe ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application
7.3.1 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024)
7.3.2 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030)
7.3.3 Europe ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Country
7.4.1 Europe ALK Positive Lung Cancer Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)
7.4.3 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China ALK Positive Lung Cancer Treatment Market Size (2019-2030)
8.2 China ALK Positive Lung Cancer Treatment Market Size by Type
8.2.1 China ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024)
8.2.2 China ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030)
8.2.3 China ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
8.3 China ALK Positive Lung Cancer Treatment Market Size by Application
8.3.1 China ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024)
8.3.2 China ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030)
8.3.3 China ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia ALK Positive Lung Cancer Treatment Market Size (2019-2030)
9.2 Asia ALK Positive Lung Cancer Treatment Market Size by Type
9.2.1 Asia ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024)
9.2.2 Asia ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030)
9.2.3 Asia ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
9.3 Asia ALK Positive Lung Cancer Treatment Market Size by Application
9.3.1 Asia ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024)
9.3.2 Asia ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030)
9.3.3 Asia ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
9.4 Asia ALK Positive Lung Cancer Treatment Market Size by Region
9.4.1 Asia ALK Positive Lung Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia ALK Positive Lung Cancer Treatment Market Size by Region (2019-2024)
9.4.3 Asia ALK Positive Lung Cancer Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 TP Therapeutics
11.4.1 TP Therapeutics Company Details
11.4.2 TP Therapeutics Business Overview
11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.4.5 TP Therapeutics Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.6.5 Eli Lilly and Company Recent Developments
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.7.5 Takeda Recent Developments
11.8 Beacon Pharma
11.8.1 Beacon Pharma Company Details
11.8.2 Beacon Pharma Business Overview
11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)
11.8.5 Beacon Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Crizotinib
Table 3. Key Players of Alectinib
Table 4. Key Players of Ceritinib
Table 5. Key Players of Brigatinib
Table 6. Key Players of Other
Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Region (2019-2024)
Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Region (2025-2030)
Table 13. ALK Positive Lung Cancer Treatment Market Trends
Table 14. ALK Positive Lung Cancer Treatment Market Drivers
Table 15. ALK Positive Lung Cancer Treatment Market Challenges
Table 16. ALK Positive Lung Cancer Treatment Market Restraints
Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global ALK Positive Lung Cancer Treatment Revenue Share by Players (2019-2024)
Table 19. Global Top ALK Positive Lung Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2023)
Table 20. Global ALK Positive Lung Cancer Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of ALK Positive Lung Cancer Treatment, Headquarters and Area Served
Table 23. Global Key Players of ALK Positive Lung Cancer Treatment, Product and Application
Table 24. Global Key Players of ALK Positive Lung Cancer Treatment, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 30. Global ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global ALK Positive Lung Cancer Treatment Revenue Share by Application (2019-2024)
Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global ALK Positive Lung Cancer Treatment Revenue Share by Application (2025-2030)
Table 34. North America ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America ALK Positive Lung Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe ALK Positive Lung Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. China ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 49. China ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 50. China ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 51. China ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia ALK Positive Lung Cancer Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia ALK Positive Lung Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia ALK Positive Lung Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
Table 69. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer ALK Positive Lung Cancer Treatment Product
Table 74. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis ALK Positive Lung Cancer Treatment Product
Table 79. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. TP Therapeutics Company Details
Table 82. TP Therapeutics Business Overview
Table 83. TP Therapeutics ALK Positive Lung Cancer Treatment Product
Table 84. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 85. TP Therapeutics Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
Table 89. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Eli Lilly and Company Company Details
Table 92. Eli Lilly and Company Business Overview
Table 93. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
Table 94. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 95. Eli Lilly and Company Recent Developments
Table 96. Takeda Company Details
Table 97. Takeda Business Overview
Table 98. Takeda ALK Positive Lung Cancer Treatment Product
Table 99. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 100. Takeda Recent Developments
Table 101. Beacon Pharma Company Details
Table 102. Beacon Pharma Business Overview
Table 103. Beacon Pharma ALK Positive Lung Cancer Treatment Product
Table 104. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)
Table 105. Beacon Pharma Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2023 VS 2030
Figure 3. Crizotinib Features
Figure 4. Alectinib Features
Figure 5. Ceritinib Features
Figure 6. Brigatinib Features
Figure 7. Other Features
Figure 8. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 14. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2023
Figure 18. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2023
Figure 20. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
Figure 22. North America ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
Figure 23. North America ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)
Figure 24. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe ALK Positive Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
Figure 28. Europe ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
Figure 29. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)
Figure 30. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China ALK Positive Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
Figure 38. China ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
Figure 39. Asia ALK Positive Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
Figure 41. Asia ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
Figure 42. Asia ALK Positive Lung Cancer Treatment Market Share by Region (2019-2030)
Figure 43. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)
Figure 53. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 60. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 62. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 64. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 65. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 66. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies